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Lipin 1 is a bifunctional protein that regulates gene transcription and, as a Mg2-dependent phosphatidic
acid phosphatase (PAP), is a key enzyme in the biosynthesis of phospholipids and triacylglycerol. We describe
here the functional interaction between lipin 1 and the nuclear factor of activated T cells c4 (NFATc4). Lipin
1 represses NFATc4 transcriptional activity through protein-protein interaction, and lipin 1 is present at the
promoters of NFATc4 transcriptional targets in vivo. Catalytically active and inactive lipin 1 can suppress
NFATc4 transcriptional activity, and this suppression may involve recruitment of histone deacetylases to target
promoters. In fat pads from mice deficient for lipin 1 (fld mice) and in 3T3-L1 adipocytes depleted of lipin 1
there is increased expression of several NFAT target genes including tumor necrosis factor alpha, resistin,
FABP4, and PPAR. Finally, both lipin 1 protein and total PAP activity are decreased with increasing adiposity
in the visceral, but not subcutaneous, fat pads of ob/ob mice. These observations place lipin 1 as a potentially
important link between triacylglycerol synthesis and adipose tissue inflammation.
Lipin 1 was first identified as the protein product of the
Lpin1 gene to which the site of a spontaneous mutation in the
fatty liver dystrophy (fld) strain of mice had been localized
(40). As the name suggests, newborn fld mice exhibit fatty liver
and hyperlipidemia that resolve at weaning (29). Adult fld mice
display dramatically reduced adiposity, insulin resistance, and
glucose intolerance (47). There are three lipin genes in verte-
brates and lipin homologs are found in most species (40).
Although implicated in adipocyte development, the function
of lipin 1 was unknown until Han et al. identified the lipin
homolog in yeast as a Mg2-dependent phosphatidic acid
phosphatase (PAP) (16). The mammalian enzyme lipin 1 ex-
hibits Mg2-dependent PAP activity and performs the next-to-
last enzymatic reaction in the synthesis of triacylglycerol (16,
46). Lipin 1 contains a haloacid dehalogenase active site in the
conserved carboxy-terminal CLIP domain necessary for lipid
phosphatase activity. However, the highly conserved amino-
terminal NLIP domain is also required for lipin activity (18).
Analysis of total PAP activity in tissues from fld mice revealed
that lipin 1 is responsible for the majority of PAP activity in
adipose tissue, skeletal muscle, heart, kidney, and lungs and
contributes significantly to total liver PAP activity (9, 18).
Mg2-dependent PAP activity has long been known to be
crucial in the synthesis of phospholipids and triacylglycerol (6).
Fatty acids, either synthesized de novo or taken up from the
circulation, are converted to acyl-coenzymes A that are then
used to acylate glycerol-3-phosphate in a stepwise fashion to
generate phosphatidic acid. Phosphatidic acid can then be uti-
lized for the synthesis of phospholipids such as phosphatidyl-
inositol and cardiolipin or dephosphorylated by a PAP enzyme
such as lipin 1 to form diacylglycerol (DAG). DAG can then be
used to form triacylglycerol and phospholipids such as phos-
phatidylcholine or phosphatidylethanolamine. Lipin 1 expres-
sion and PAP activity is induced in 3T3-L1 cells and the liver
upon glucocorticoid stimulation, during adipocyte differentia-
tion, and upon fasting in the liver (12, 40, 42, 59). Posttran-
scriptionally, PAP activity has been hypothesized to be regu-
lated via changes in its intracellular localization (3, 18). Lipin
1 is highly phosphorylated; however, in 3T3-L1 cells the phos-
phorylation of lipin 1 does not affect its intrinsic enzymatic
activity (18, 24). Instead, the localization of lipin 1 correlates
with its phosphorylation state. Of note, indirect immunofluo-
rescence studies have demonstrated considerable lipin 1 local-
ization in the nucleus of cells (38–40).
Lipin 1 is a multifunctional protein that has both enzymatic
activity and the ability to regulate transcription (reviewed in
references 46 and 48). Lipin proteins do not contain DNA-
binding domains but instead regulate gene expression indi-
rectly by interacting with transcription factors and regulating
their activity. For example, lipin 1 interacts with and activates
PPAR transcriptional activity in partnership with the PPAR
coactivator PGC-1 (12). The effect of lipin 1 on PPAR
transcription does not require lipin 1 PAP activity, demonstrat-
ing that the enzymatic activity of lipin 1 can be functionally
separated from the ability of lipin 1 to regulate transcription.
In yeast, lipin plays a crucial role in nuclear membrane forma-
tion (50), at least in part by inhibiting expression of several
genes necessary for phospholipid synthesis. Subsequent work
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in yeast cells has shown that the yeast homolog of lipin requires
intact PAP activity for function (15).
The ability of lipin 1 to activate PPAR transcription re-
quires a direct interaction between the two proteins, and chro-
matin immunoprecipitation (ChIP) analysis suggests that this
interaction occurs in the nucleus at the promoters of PPAR-
regulated target genes (12). A recent study demonstrated that
lipin 1 interaction with PPAR allows lipin 1 to act as a tran-
scriptional coactivator for PPAR in 3T3-L1 adipocytes and
suggested that the ability of lipin 1 to coactivate PPAR was
important for 3T3-L1 adipocyte differentiation (28). Lipin 1
seems to interact with PPAR through a hydrophobic motif
similar to domains used by other coactivators to interact with
nuclear hormone receptors. This binding motif is found in the
CLIP domain of lipin 1 and is adjacent to the PAP catalytic
domain (12). Previous work from our laboratory suggested that
lipin 1 increases the transcriptional activity of the PPAR/
PGC-1 complex via recruitment of transcriptional coactiva-
tors with histone-modifying enzymatic activity, such as p300
(12).
We describe nuclear factor of activated T cells c4 (NFATc4)
here as a new lipin 1-interacting partner and demonstrate the
functional consequence of this interaction. NFAT transcrip-
tion factors are activated by cytosolic calcium and are recog-
nized to play an important role in the activation of cytokine
expression and differentiation of immune cells (20). NFATc2
and NFATc4 have also been implicated in both adipocyte
differentiation and expression of adipokines. Mice deficient for
both NFATc2 and NFATc4 have decreased production of re-
sistin in adipose tissue and are resistant to diet-induced obesity
(55). The role of lipin 1 in triacylglycerol synthesis, when com-
bined with its ability to modulate the activity of a transcription
factor that regulates expression of cytokines and adipokines,
positions lipin 1 as a potential regulator of the negative con-
sequences of increased triacylglycerol deposition in adipocytes.
MATERIALS AND METHODS
Cell culture and treatments. 3T3-L1 preadipocytes were maintained in Dul-
becco modified Eagle medium (DMEM) with 10% newborn bovine serum.
Differentiation of 3T3-L1 preadipocytes was initiated with a mix of insulin (0.25
U/ml), 3-isobutyl-1-methylxanthine (0.5 mM), and dexamethasone (0.25 M) in
DMEM plus 10% fetal bovine serum (FBS). On day 4 and every other day
thereafter, the differentiation medium was replaced with DMEM containing
10% FBS. BHK cells were maintained in DMEM plus 10% FBS.
Electrophoretic mobility shift assay (EMSA). Double-stranded synthetic oligo-
nucleotides were 5 end labeled with [-32P]dATP. The sequences were as fol-
lows: NFAT (sense), 5-CGCCCAAAGAGGAAAATTTGTTTCATA-3; and
NFAT (antisense), 5-TATGAAACAAATTTTCCTCTTTGGGCG-3. The
PPAR oligonucleotide was from PPAR binding site in the human apolipopro-
tein C-III promoter (sc-2587; Santa Cruz Biotechnology). Standard binding
reactions were carried out in 10% glycerol (vol/vol), 20 mM HEPES (pH 7.9),
100 mM KCl, 1 mM dithiothreitol, 1 mM EDTA, 1 g of poly(dI-dC), and
100,000 cpm of DNA probe in a total volume of 20 l. The reaction mixtures
were then incubated for 1 h at room temperature, and protein-DNA was sepa-
rated on 4% nondenaturing polyacrylamide gels. Electrophoresis was performed
at a constant voltage of 160 V for 90 min at 4°C. The gels were then dried under
vacuum and autoradiographed at –80°C for several days. For supershift analyses,
antibodies against NFAT (FLAG), lipin (HA), and NFATc4 antibody (sc-
13036X; Santa Cruz) were used. Incubation with antibodies was on ice for 1 h
prior to addition of the 32P-labeled probe.
ChIP. ChIP assays were performed by using a ChIP assay kit (Upstate Bio-
technology, Inc.) according to the manufacturer’s instructions. Briefly, the dif-
ferentiated 3T3-L1 cells were cross-linked with 1% (vol/vol) formaldehyde at
37°C for 10 min and harvested. The cells were sonicated for 30 s five times and
centrifuged at 13,000 rpm for 10 min at 4°C. The cell supernatant was precleared
with a salmon sperm DNA-protein A-agarose slurry for 30 min at 4°C with
agitation. The specific DNA-bound transcription factor complexes were precip-
itated overnight with 4 g of nonimmune, NFATc4 (Santa Cruz), lipin 1 (LAb1
[23]), or acetylated histone H3 (Millipore) antibody at 4°C before the addition of
salmon sperm DNA-protein A-agarose slurry. The antibody-chromatin com-
plexes were eluted from the salmon sperm DNA-protein A-agarose slurry, and
cross-links were reversed with 5 M NaCl at 65°C for 4 h. The protein was
removed from DNA digestion with 10 mg of proteinase K/ml at 45°C for 1 h, and
the DNA was recovered from the solution by phenol-chloroform extraction. PCR
was performed with total DNA (input control) and immunoprecipitated DNA
using promoter-specific primers (see the supplemental material). The PCR prod-
ucts were subjected to electrophoresis on 1% agarose gels.
Coimmunoprecipitations and electrophoretic analysis. Transfected cells (10-cm
plate) were homogenized by glass-Teflon at 1,000 rpm in 1 ml of buffer A (50 mM
-glycerophosphate, 50 mM NaF, 1 mM EDTA, 1 mM EGTA, and 10 mM
sodium phosphate [pH 7.4] plus 0.1% NP-40 and protease inhibitors). Cellular
debris was cleared by centrifugation at 13,000 rpm for 15 min, and the superna-
tant was retained. The FLAG, myc, and hemagglutinin (HA) antibodies were
incubated with protein G-agarose at room temperature for 2 h by gentle inver-
sion and then incubated with aliquots of 400-l protein lysates at 4°C overnight.
After centrifugation at 6,000 rpm for 15 s, the supernatant was removed, and the
beads were washed three times with 1 ml of buffer A. The beads were suspended
in 80 l of sodium dodecyl sulfate (SDS) gel loading buffer, boiled for 5 min, and
centrifuged at 6,000 rpm for 1 min. The supernatant and cell lysates were
analyzed by Western blotting with antibodies to NFATc4 (H-74; Santa Cruz),
lipin 1 (22), lipin 2 (14), FLAG (M2), HA (12CA5), and myc (9E10), as previ-
ously described (18).
Nuclear extracts. Total nuclear fractions were prepared from 3T3-L1 cells by
the following method. 3T3-L1 cells (10-cm plate) were washed twice with ice-cold
phosphate-buffered saline (PBS) buffer and incubated at 4°C for 5 min with 1 ml
of hypotonic buffer (10 mM Tris [pH 7.6], 10 mM NaCl, 3 mM MgCl2, 0.5%
NP-40, and protease inhibitors). The cells were scraped from the dish and
centrifuged at 130  g for 5 min. The supernatants were used as cytosolic
fractions, and the pellet was suspended in 500 l of nuclear extraction buffer (5
mM HEPES [pH 7.9], 26% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 0.4 M NaCl,
0.5 mM dithiothreitol, and protease inhibitors), incubated at 4°C for 30 min, and
then centrifuged at 30,000  g for 20 min.
Northern analysis. For Northern blot analysis, cells were washed with ice-cold
PBS and total RNA was extracted with TRIzol RNA isolation reagent (Invitro-
gen) according to the manufacturer’s instructions. A 15-g portion of total RNA
extracted from differentiated 3T3-L1 adipocytes was denatured by heating in
denaturing buffer (20 mM morpholinepropanesulfonic acid, 1 mM EDTA, 2.2 M
formaldehyde, 50% formamide, bromophenol blue, 5 mM sodium acetate; pH
7.0) at 55°C for 15 min and then electrophoresed on 1.2% agarose-formaldehyde
gel. The gel was transferred to Hybond membranes by using 10 SSC (1.5 M
NaCl, 150 mm sodium citrate) overnight. The membrane was washed in 2 SSC,
cross-linked by UV light (254 nm; UV Stratalinker 1800; Stratagene). The mem-
brane was rinsed in 5 SSPE (1 SSPE is 0.18 M NaCl, 10 mM NaH2PO4, and
1 mM EDTA [pH 7.7]), and then sequentially probed with [-32P]dATP-labeled
probes in hybridization buffer (0.5 M NaPO4 [pH 7.2], 7% SDS, 1 mM EDTA,
1% bovine serum albumin) at 61°C overnight. After hybridization, the Northern
blot was washed twice with 2 SSC–0.1% SDS for 15 min and once with 1
SSC–0.1% SDS for 15 min and then exposed to X-ray film or phosphorimage
screens (Molecular Dynamics) for 24 to 72 h depending on the signal intensity.
RT-PCR. Total RNA from 3T3-L1 cells or white adipose tissue (1 g) was
reverse transcribed in a final incubation volume of 20 l using an Omniscript RT
kit (Qiagen) at 37°C for 1 h. The resulting first-strand cDNA was subjected to
real-time PCR using the SYBR green detection system in a final volume of 20 l.
PCR amplifications were performed as follows: 5 min at 94°C for denaturation,
followed by 40 cycles of 1 min at 94°C, 1 min at 55°C, and 1 min at 72°C. reverse
transcription-PCR (RT-PCR) quantitation was performed according to the
method of Pfaffl (41). The data shown are the fold change in expression from the
control. The primer sequences are given in the supplemental material.
Enzyme-linked immunosorbent assay. A tumor necrosis factor alpha (TNF-)
enzyme-linked immunoassay kit (mouse TNF-; eBioscience, San Diego, CA)
was used according to the manufacturer’s instructions to quantitate TNF- levels
in media from 3T3-L1 cells.
Transfection and luciferase reporter assay. BHK cells were transfected with
expression vectors and luciferase reporter vectors with Lipofectamine 2000 re-
agent (Invitrogen). A -galactosidase expression vector was also cotransfected to
measure the transfection efficiency. Luciferase activity was measured by using a
dual-luciferase reporter assay system (Promega) according to the manufacturer’s
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instructions, and the luciferase activity was normalized to the -galactosidase
activity.
Measurement of PAP activity. PAP activity was measured as previously de-
scribed except the cells were homogenized in buffer A plus 10 mM Triton X-100
for a final concentration of 2 mM Triton X-100 and a final concentration of
phosphatidic acid (PA) of 0.2 mM (18). The data are expressed as nmol of PA
dephosphorylated/min/mg of protein.
Adenovirus constructs and expression vectors. Adenoviral constructs for lipin
1 shRNA and HA-tagged lipin 1b, as well as expression plasmids for HA-tagged
lipin 1b the D712E, I-mut, L-mut, N, and C expression plasmids, and the
ACO3-tk-luc reporter plasmid have all been previously described (12, 18). The
FLAG-tagged NFATc4, constitutively active NFATc4 containing Ser 168 and
170 mutated to Ala (NFAT-CA), and the NFAT-tk-luc reporter plasmid were
generously provided by Chi-Wing Chow, Albert Einstein College of Medicine
(56). The Ad-EGFP-VIVIT was made by generating an adenoviral expression
vector containing enhanced green fluorescent protein (EGFP) fused in frame
with two copies of the NFAT inhibitory peptide MAGPHPVIVITGPHEE (1).
For infection of 3T3-L1 cells, differentiated adipocytes at 9 to 15 days postdif-
ferentiation were infected with adenovirus for 3 to 4 days before harvest. The
infection efficiency as determined by GFP expression was 	95%. Myc-tagged
histone deacetylase (HDAC) expression vectors have been previously described
(32).
Recombinant Lipin 1. The coding sequence of lipin 1b was subcloned down-
stream of the glutathione S-transferase (GST) tag in the pEBG expression vector
to generate pEBG-lipin 1b. Ten 15-cm plates of 293T cells were transfected with
20 g of pEBG-lipin 1b and harvested in buffer A plus 1% Triton X-100.
GST-lipin 1b was purified with glutathione-Sepharose 4B beads (GE Healthcare)
according to the manufacturer’s instructions.
Mouse studies. Breeding colonies of fld and ob/ob mice were established at
Washington University School of Medicine from mice originally obtained from
the Jackson Laboratory (Bar Harbor, ME). fld mice were genotyped according to
previously published protocols (40). Adipose tissue was collected from wild-type
and fld/fld mice at 3 to 4 months of age. Adipose tissue was collected from female
ob/ob mice and sex- and age-matched lean control mice at the indicated ages. All
animal experiments were approved by the Washington University School of
Medicine Animal Studies Committee conformed to criteria outlined in the Na-
tional Institutes of Health Guide for the Care and Use of Laboratory Animals.
RESULTS
Lipin 1 interacts with NFATc4. Using lipin 1 as bait in a
two-hybrid screen of a 3T3-L1 expression library, we identified
NFATc4 as a potential interacting protein; NFATc4 was
present in two independent clones out of nine potential inter-
actors (data not shown). As shown in Fig. 1A, immunoprecipi-
tation of HA-tagged lipin isolated FLAG-tagged NFATc4 and
vice versa immunoprecipitations of FLAG-NFATc4 from the
same lysates pulled down HA-tagged lipin 1. To examine the
functional significance of the lipin 1-NFATc4 interaction, we
used a reporter gene that contains the NFAT binding motif
from the interleukin-2 (IL-2) promoter (Fig. 1C). NFATc4
expression strongly activated the reporter while coexpression
of lipin 1 decreased activity by ca. 50%. The repressive effect of
lipin 1 was dependent on the ability to interact with NFATc4.
As seen in Fig. 1A, a lipin 1 construct deleted for the entire
carboxy-terminal CLIP domain (C) neither interacted with
NFATc4 (Fig. 1A) nor repressed NFATc4 transcriptional ac-
tivity (Fig. 1C). In contrast, lipin 1 with the NLIP domain
deleted (N) was capable of both interaction and repression.
Because lipin 1 is known to serve as a coactivator of PPAR,
we were surprised that lipin 1 exhibited repressive effects on
NFAT transcriptional activity. We next tested the ability of
lipin 1 to interact with and transcriptionally activate PPAR
under identical conditions. Figure 1B shows that similar re-
gions of lipin 1 interacted with PPAR, whereas Fig. 1D shows
that lipin 1 activated a PPAR-responsive reporter construct,
ACO3-tk-luc, as previously reported (12). As seen with NFAT,
the CLIP domain is required for both PPAR interaction and
transcriptional activation. These results suggest that lipin 1 can
act to repress or activate transcription factors.
We previously reported that lipin 1 requires an LxxIL motif
in the carboxy terminus to interact with PPAR (12). There
are two pentameric hydrophobic residue-rich motifs in this
region of lipin 1 (IIxxI at residues 706 to 711 and LxxIL at
residues 719 to 724). When I723 and L724 were mutated to
phenylalanine (L-mut), lipin 1 was unable to interact with
NFATc4 and had no repressive effect on reporter gene activity.
However, lipin 1 that contained I706 and I707 mutated to
phenylalanine (I-mut) retained the ability to interact with and
repress NFATc4 transcriptional activity (Fig. 1E and G). This
was similar to the interaction results previously reported for
PPAR (also shown in Fig. 1F and H). In contrast, although
mutation of the first aspartic acid residue in the lipin 1 catalytic
motif to glutamic acid (D712E) did not affect the interaction of
lipin 1 and PPAR (Fig. 1F), it eliminated the ability of lipin
1 to interact with NFATc4 (Fig. 1E). The D712E mutant also
failed to repress NFATc4 transcriptional activity (Fig. 1G) but
still coactivated PPAR (Fig. 1H). The I-mut, L-mut, and
D712E mutants all lack enzymatic activity, but only I-mut mutant
can interact with and repress NFATc4 transcription. Therefore,
the inability of the D712E mutant to repress NFATc4 tran-
scriptional activity is due to lack of association with lipin 1
rather than a loss of PAP activity. These data also indicate that
there are subtle differences in the requirements for NFATc4
and PPAR for binding to lipin 1; the D712E mutant can
interact with PPAR but not NFATc4.
PGC-1 is a transcriptional coactivator that interacts with lipin
1 and acts synergistically with lipin 1 to activate the PPAR
transcriptional activity. Therefore, we tested whether PGC-1
modulates the repressive effects of lipin 1 on NFATc4-responsive
promoters. Figure 2A shows that PGC-1 coimmunoprecipi-
tates PPAR but not NFATc4. Likewise, while PGC-1 in-
creases the transactivation of the PPAR responsive reporter
ACO3tk reporter either with or without lipin 1, there was no
effect on NFATc4 transcriptional activity (Fig. 2B). Thus,
PGC-1 insufficiency is not causing nonspecific squelching of
NFATc4 activity, and the ability of lipin 1 to repress NFATc4
transcriptional activity is independent of PGC-1.
There are four calcium responsive NFAT isoforms and all
are expressed in 3T3-L1 adipocytes, with NFATc1 and -c3
constitutively expressed and NFATc2 and -c4 induced during
adipocyte differentiation (55). Despite similar expression of
the FLAG-tagged NFAT proteins, only NFATc2 and -c4
showed significant levels of interaction with lipin 1 (Fig. 2C).
The NFATc4 clone from the two hybrid screen that identified
NFATc4 as a potential lipin 1 interactor only contained amino
acids 501 to 901. Expression of this portion of NFATc4 pro-
duced a truncated NFATc4 protein that retained the ability to
interact with lipin 1 by coimmunoprecipitation (data not shown).
Therefore, the specific residues required for interaction with
lipin 1 are contained within the RHD/DNA-binding domain
and carboxy terminus of NFATc4.
Lipin 1 can interact with activated NFAT. NFAT-mediated
transcription is activated by intracellular calcium signaling, and
in unstimulated cells hyperphosphorylated NFAT is found in
the cytoplasm (20). Calcium mobilization activates calcineurin,
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FIG. 1. Lipin 1b interacts with NFATc4 and represses transcriptional activity. (A) BHK cells were transfected with expression vectors for
EGFP, FLAG-NFATc4 (NFAT), HA-lipin 1 (lipin), and the lipin 1 deletion mutants lip-C (containing amino acids 1 to 641) and lip-N
(containing amino acids 107 to 924). Cell extracts were subjected to immunoprecipitation with either anti-FLAG or anti-HA antibodies. Immune
complexes were resolved by SDS-PAGE, transferred to nitrocellulose, and immunoblotted with antibodies to the epitope tag of the indicated
proteins. (B) BHK cells were transfected as in panel A, but with FLAG-tagged PPAR (PPAR) instead of NFATc4. Immune complexes were
isolated and immunoblotted as in panel A. (C) BHK cells were transfected with the indicated combinations of FLAG-NFATc4, HA-lipin 1, lipin
1 deletion mutants, and the NFAT-tk-luc reporter construct. BHK cells transfected with pSV-gal served as a control for transfection efficiency.
The data shown are the relative light units produced by luciferase activity normalized to -galactosidase expression and are expressed relative to
NFATc4 activity alone. Error bars represent standard error (n 
 4). Student t test indicates significant difference (P  0.05) from NFATc4 alone
(). (D) Reporter activity of PPAR was performed as in C using the ACO3-tk-luc reporter construct (n 
 4). The data expressed relative to
PPAR alone. (E) BHK cells were transfected with expression vectors for FLAG-NFATc4, HA-lipin 1, and the lipin 1 point mutants D712E, I-mut,
and L-mut. Coimmunoprecipitations were performed as in panel A. (F) Transfections and coimmunoprecipitation performed as in panel E, except
PPAR was transfected instead of NFATc4. (G) NFATc4 reporter analysis with lipin 1 point mutants was performed as in panel C (n 
 3).
(H) PPAR reporter analysis with lipin 1 point mutants was performed as in panel D (n 
 2).
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also known as PP2B, a calcium-sensitive phosphatase that de-
phosphorylates NFAT. This leads to NFAT nuclear localization
and transcriptional activation (20). Yang et al. demonstrated that
mutation of the calcineurin-regulated phosphorylation sites S168
and S170 to alanine creates a constitutively active NFATc4
(NFAT-CA) (Fig. 3B) (56). NFAT-CA interacts with lipin 1 to
an extent similar to that of wild-type NFATc4 (Fig. 3A). De-
spite an overall increase in transcriptional activity the consti-
tutively nuclear NFAT-CA was still effectively repressed by
lipin 1 (Fig. 3B). Although treatment of cells with A23187
increased NFAT transcriptional activity	2-fold, this effect was
reversed by lipin 1. As shown in Fig. 3C, constitutively active
calcineurin (CnA) activated the NFAT reporter and this ac-
tivation was also largely reversed by lipin 1 overexpression.
We next examined the interaction between endogenous lipin
1 and NFATc4 in 3T3-L1 adipocytes. Cyclosporine (CsA) in-
hibits calcineurin thus blocking NFAT cytosolic to nuclear
transition (Fig. 3D), while A23187 promotes NFAT nuclear
accumulation (Fig. 3D). Lipin 1 nuclear accumulation was
unaffected by either treatment. Interaction between endoge-
nous nuclear lipin 1 and NFATc4 directly corresponded to the
amount of NFATc4 present in the nucleus, since CsA treat-
ment decreased the amount of NFAT in the nucleus and re-
sulted in less NFATc4-lipin 1 interaction, whereas A23187
treatment increased nuclear NFAT as well as the amount of
NFATc4 interacting with lipin 1. Together, these results sug-
gest that lipin 1-mediated repression of NFAT transcriptional
activity occurs after NFAT mobilization and activation by cal-
cium, perhaps in the nucleus at the level of DNA binding.
It has been previously reported that phosphorylation of
NFATc4 by mTORC1, the rapamycin-sensitive mTOR com-
plex, promotes NFATc4 nuclear export (57). Lipin 1 also con-
tains rapamycin-sensitive phosphorylation sites, suggesting
that lipin 1 is downstream of mTORC1 as well (18, 24). Rapa-
mycin treatment modestly increases the amount of lipin 1 in
the nucleus, suggesting that lipin 1 nuclear localization is at
least partially dependent on mTORC1 (data not shown). A
recently published study detailing the mechanisms controlling
lipin 1 nuclear localization confirms our observation that rapa-
mycin increases lipin 1 nuclear localization (38). Thus, rapa-
mycin treatment opposes NFAT nuclear export and promotes
lipin 1 nuclear localization.
NFATc4 provides specificity for lipin 1 repression. Although
NFAT transcription factors can bind to DNA as monomers or
dimers, the NFATs frequently activate gene expression at com-
posite binding elements through cooperative interactions with
other transcription factors (44). The ubiquitous jun/Fos complex,
AP-1, was found to bind in a cooperative fashion with NFAT at a
composite NFAT binding element in the IL-2 promoter. The
reporter gene experiments shown in Fig. 1 utilized the composite
NFAT:AP-1 binding element. In 3T3-L1 adipocytes, C/EBP
and NFATc4 have been shown to cooperatively activate the
PPAR2 promoter (54). We sought to determine whether the
identity of the NFAT binding partner affects the ability of lipin
1 to repress NFAT transcriptional activity. Cotransfection of
C/EBP did not block the ability of lipin 1 to interact with
NFATc4 (Fig. 3E). As previously reported, cotransfection of
NFATc4 and C/EBP caused an additive increase in the tran-
scriptional activation of the PPAR2 proximal promoter (Fig.
3F) but had no effect on the NFAT-tk-luc promoter, which
does not have a C/EBP response element (data not shown).
Cotransfection of lipin 1 repressed the PPAR2 promoter in a
manner dependent on NFATc4 expression (Fig. 3F). There-
fore, lipin 1 can repress NFATc4 in the context of at least two
different composite elements.
Lipin 1 interacts with NFATc4 bound to DNA and is present
at the promoters of NFAT target genes. Since lipin 1 expres-
sion inhibited nuclear NFAT, we speculated that lipin 1 may
either bind directly to NFAT at the promoters of target genes
or block NFAT binding to DNA. We sought to determine
whether lipin 1 blocks the ability of NFAT to bind to DNA in
vitro using an EMSA. We found that the coexpression of lipin
1 did not affect NFATc4 binding to DNA (Fig. 4A). In fact,
coexpression of lipin 1 and NFATc4 resulted in the formation
of a larger DNA-protein complex, seen as a band of retarded
mobility. The formation of the higher mobility DNA-binding
FIG. 2. Lipin 1does not require PGC-1 to repress NFATc4, and
lipin 1 can suppress both NFATc2 and NFATc4. (A) Myc-tagged PGC-1
(PGC-1) was transfected with FLAG-tagged NFATc4 (NFAT) or
FLAG-tagged PPAR (PPAR). Coimmunoprecipitations were per-
formed with anti-myc antibodies and immunoblotted with anti-FLAG
(top and bottom panels) or anti-myc antibodies (middle panel).
(B) Reporter activity of PPAR or NFATc4 in the presence of
PGC-1 and lipin 1 (n 
 3 or 2, respectively). , significant difference
(0.05) from PPAR plus lipin 1 alone. (C) BHK cells were trans-
fected with expression vectors for FLAG-tagged NFATc1 to -c4 and
either HA-tagged lipin 1 or the HA-tagged lipin 1 mutant D712E.
Coimmunoprecipitations were performed as in Fig. 1A.
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complex required NFATc4, since lipin 1 alone showed no
complex formation. The addition of unlabeled oligonucleotide
containing the NFAT binding site eliminated both bands. In
the right hand panel, the identity of the complex is demon-
strated by the indicated gel shifts with antibodies to either
NFAT (FLAG) or lipin 1 (HA). Overexpression of lipin 1 with
PPAR also induced the formation of a larger complex (Fig.
4B). As an additional measure of specificity, recombinant
GST-tagged lipin 1 was added to the NFATc4-DNA binding
complex generated from cells expressing NFATc4 only. This
FIG. 3. Lipin 1 represses activated NFATc4 and NFATc4 bound to different composite elements. (A) BHK cells were transfected with the
indicated expression vectors for FLAG-NFATc4, constitutively active NFATc4 (FLAG-NFAT-CA), and HA-lipin 1. Coimmunoprecipitations
were performed as in Fig. 1A. (B) NFATc4 reporter gene analysis with NFATc4, constitutively active NFATc4, and lipin 1 were performed as
described in Fig. 1C (n 
 3). (C) Reporter gene analysis of BHK cells transfected with expression vectors for FLAG-NFATc4 and HA-Lipin 1 and
a constitutively active calcineurin vector (CnA) as indicated. At 24 h after transfection the indicated cells were treated with 1 M A23187 for
24 h. NFATc4 reporter analysis was performed as in Fig. 1C (n 
 3). (D) Differentiated 3T3-L1 cells, were either untreated (control), or treated
with CsA (5 g/ml), or A23187 (1 M) plus phorbol myristate acetate (PMA; 50 nM) for 18 h. After treatment, nuclear extracts were prepared
and antibodies to endogenous lipin 1 and NFATc4 were used for coimmunoprecipitation. (E) The top panel is a schematic of NFATc binding to
two different composite elements. For the bottom panel, BHK cells were transfected with expression vectors for FLAG-NFATc4, HA-C/EBP,
and HA-lipin 1b. Coimmunoprecipitation of NFATc4 was performed as in Fig. 1A. (F) BHK cells were transfected with the indicated expression
vectors along with the NFAT:C/EBP-responsive reporter from the promoter of PPAR. NFATc4 reporter analysis was performed as in Fig. 1C
(n 
 4).  and #, significant difference (P  0.05) from NFATc4 alone () or from NFAT plus C/EBP (#).
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FIG. 4. Lipin 1 forms a complex with both NFATc4 and PPAR on DNA in vitro and is present at the promoter of NFAT target genes in vivo.
(A) BHK cells were transfected with expression vectors for FLAG-tagged NFATc4, HA-tagged lipin 1b, or both. The DNA bound complexes were
then analyzed by EMSA. The first lane contains labeled oligonucleotide only, while the second lane is lysates from EGFP-transfected cells. The
free probe (free), NFATc4-DNA complex (NFAT), and the lipin 1-NFATc4-DNA complex (Lip-NFAT) and antibody-induced supershift
(Supershift) are indicated. The right panel shows the specificity of NFAT binding via competition with 100-fold of excess unlabeled oligonucleotide
(lanes C) and verifies the identity of the NFATc4 and lipin 1-NFATc4 bands by preincubation with antibodies specific for the epitope tags of
NFATc4 and lipin 1, FLAG (lane F) and HA (lane H), respectively. (B) BHK cells were transfected with expression vectors for FLAG-tagged
PPAR and HA-tagged lipin 1b. Gel mobility shift assays performed as described for panel A using an oligonucleotide derived from the PPAR
binding site in the apoE III promoter. (C) BHK cells were transfected and binding reactions performed as described above. Where indicated, the
DNA-binding reaction was supplemented with recombinant lipin 1 (L) or recombinant lipin 1 that was heat inactivated by boiling for 10 min ().
(D) Fully differentiated 3T3-L1 adipocytes were infected with adenovirus expressing LacZ shRNA (LacZ), lipin 1 shRNA (shRNA1), or
HA-tagged lipin 1. At 3 to 4 days after infection, adipocytes were harvested for protein analysis. The top panel shows the results of Western blot
analysis of lipin 1 expression in LacZ shRNA (LacZ)-, lipin 1 shRNA (shRNA1)-, or HA-tagged lipin 1b-expressing cells. The bottom panel shows
results obtained with total Mg2-dependent PAP in adenovirus-infected cells. (E) 3T3-L1 adipocytes infected with adenovirus expressing LacZ
shRNA (LacZ), lipin 1 shRNA (shRNA1), or HA-tagged lipin 1 were used to prepare nuclear extracts to analyze NFATc4 binding activity. Where
indicated, cold competitor oligonucleotide or antibodies to endogenous NFATc4 were included in the reactions. (F) Semiquantitative ChIP assays
for the Tnf, Fabp4, and Gapdh promoters in 3T3-L1 cells infected with adenovirus expressing shRNA targeting LacZ or lipin 1. Either no antibody,
antibodies specific for NFATc4, lipin 1, or nonimmune antibodies were used to immunoprecipitate chromatin-bound proteins from untreated,
control cells (rows C) or cells treated with A23187 (1 M) plus PMA (50 nM) for 18 h (AP). PCR was performed for the indicated number of
cycles using primer pairs specific for the Tnf, Fabp4, and Gapdh promoters. Input is PCR amplification of 1% of the amount of lysates used for












induced the formation of a retarded mobility band similar to
that seen with the overexpression of lipin 1 and NFATc4 (Fig.
4C). Denaturing the recombinant lipin 1 () by boiling at 95°C
for 10 min before addition to the binding reaction eliminated
the complex. Thus, lipin 1 can bind to the NFATc4-DNA
complex even when supplied from an exogenous source and
after the NFATc4-DNA complex is formed.
We next confirmed that lipin 1-NFATc4 complex formed on
DNA occurs with endogenous proteins. The NFATs are primarily
known for their role in T-cell activation and development but
have also been shown to play a role in adipocyte development and
expression of several adipocyte-specific genes including FABP4,
PPAR, and resistin (19, 55, 56). We chose 3T3-L1 adipocytes
as a model system because they express high levels of lipin 1
and, as previously mentioned, all four isoforms of calcium-
regulated NFAT (NFATc1 to -c4) (18, 55). However, both
embryonic fibroblasts from fld mice and lipin 1-deficient
3T3-L1 cells have a decreased ability to differentiate into adi-
pocytes and show decreased expression of the master regula-
tors of adipogenesis (C/EBP and PPAR), indicating that
lipin 1 is essential for adipocyte differentiation (28, 39, 42).
Precisely how the loss of lipin 1 prevents adipocyte differenti-
ation is not completely clear, but it is likely to have pleiotropic
effects on adipocyte differentiation through both transcrip-
tional and lipid biosynthetic pathways. There is evidence that
repression of the NFAT genes is essential to allow adipocyte
differentiation as constitutive activation of NFAT, either through
expression of activated NFAT or activated calcineurin, inhibits
3T3-L1 adipocyte differentiation (36, 37). So, in order to avoid
confounding effects on differentiation from the loss of lipin 1,
we reduced lipin 1 expression in mature 3T3-L1 adipocytes. At
3 to 4 days after infection with lipin 1 shRNA adenovirus, lipin
1 protein and total PAP activity were both decreased by 	95%
(Fig. 4D), whereas infection with HA-lipin 1 adenovirus in-
creased lipin 1 protein and PAP activity by 5-fold. Lysates
from LacZ-infected 3T3-L1 adipocytes analyzed for NFAT
complex formation (Fig. 4E) demonstrated an upper band and
a lower band, a finding similar to what was observed after
transient transfection in BHK cells (Fig. 4A). Both bands were
eliminated by competition with unlabeled oligonucleotides and
were partially supershifted by the addition of NFATc4 anti-
body to the reaction mix. Ablation of lipin 1 expression with
shRNA increased the relative level of the lower band at the
expense of the upper band, while forced expression of lipin 1
did the opposite.
Since lipin 1 can bind to NFAT-DNA complexes, ChIP was
used to determine whether lipin 1 is present at the promoters
of genes that contain NFATc4 response elements. We show
that immunoprecipitation of either NFATc4 or lipin 1 results
in the isolation of genomic DNA from the promoters of TNF-
or FABP4, but not GAPDH (glyceraldehyde-3-phosphate de-
hydrogenase) (Fig. 4F). Thus, semiquantitative ChIP analyses
demonstrate that in 3T3-L1 cells both lipin 1 and NFATc4 are
present at the promoters of NFAT target genes, and the pres-
ence of both is increased upon NFATc4 activation. When
shRNA targeting lipin 1 is used, there is a significant decrease
in the amount of lipin 1 found at the promoters of NFAT
target genes with little, if any, effect on the amount of NFAT
found at these promoters. This observation, and the ability of
endogenous lipin 1 to form a complex with NFATc4 and DNA
as measured by EMSA analysis, suggests that lipin 1 binds to
NFATc4 at the promoters of NFAT target genes in native
chromatin.
Lipin 1 recruits a HDAC to repress NFATc4 transcription.
Since lipin 1 appears to have no effect on the ability of NFATc4
to bind to DNA, yet represses NFATc4 transcriptional activity,
we hypothesized that the repressive effects of lipin 1 on NFAT
transcriptional activity might involve active recruitment of a
transcriptional repressor. A common mechanism of transcrip-
tional corepression involves the recruitment of HDACs to the
promoters of target genes that deacetylate open chromatin,
causing it to close, and thereby repressing transcriptional ac-
tivation (32). Trichostatin A (TSA) inhibits class I and class II
HDAC enzymatic activity, thus relieving HDAC-mediated re-
pression. As shown in Fig. 5A, TSA had no effect on the
activity of NFATc4 alone, but the repression of NFATc4 by
lipin 1 was eliminated. There was no substantial change in the
interaction of lipin 1 with NFATc4 (Fig. 5B). To more directly
address how lipin 1 might recruit HDACs to NFAT-regulated
target genes, we performed coimmunoprecipitation analyses
between lipin 1 and HDAC1 to -4. As seen in Fig. 5C, HDAC1
and -3 can both coimmunoprecipitate with lipin 1. As a func-
tional measure of HDAC recruitment to NFAT target genes,
we used antibodies targeting acetylated histone H3 to isolate
DNA sequences surrounding NFAT binding sites, both before
and after calcium mobilization and with or without lipin 1
depletion by shRNA. As shown in Fig. 5D, the loss of lipin 1
results in increased histone H3 acetylation at regions surround-
ing NFAT binding sites. When combined with the sensitivity of
lipin 1-mediated repression of NFAT to TSA and the ability of
lipin 1 to interact with HDAC1 and -3, these results suggest
that lipin 1 recruits HDAC activity to NFAT-responsive pro-
moters to inhibit transcription via chromatin deacetylation.
Analysis of NFAT-Lipin 1 in 3T3-L1 cells. Lipin 1 depletion
in 3T3-L1 adipocytes led to an increase in the expression of
several NFAT target genes, including FABP4, PPAR, resis-
tin, IL-6, and TNF- (Fig. 6A). This further supports the
notion that lipin 1 represses NFAT transcriptional activity. To
ensure that the lipin 1 shRNA did not induce nonspecific effects
due to off target silencing, a second independent shRNA target-
ing lipin 1 was used (shRNA2); it generated similar effects on
gene expression as shRNA1 (Fig. 6A). RT-PCR analyses were
confirmed by Northern blot (Fig. 6B). Importantly, the induction
of gene expression caused by lipin 1 knockdown was reversed
by the addition of CsA, suggesting that the effects of lipin 1
knockdown by shRNA occur through NFAT transcription. We
confirmed that the effects of lipin 1 knockdown by shRNA on
mRNA expression occur through NFAT transcriptional activ-
ity by coexpression of an EGFP-VIVIT peptide fusion protein,
a more specific inhibitor of calcineurin-mediated dephosphor-
ylation of NFAT than CsA (1). Figure 6C shows that EGFP-
VIVIT completely reverses the induction of TNF- message
caused by loss of lipin. We also investigated the consequence
of lipin 1 overexpression in 3T3-L1 adipocytes. However,
despite a substantial increase in lipin 1 protein only TNF-
demonstrated a significant decrease in expression, while other
NFAT targets tested showed a nonsignificant trend toward
repression (Fig. 6D). Figure 6E shows that, consistent with the
interaction studies in Fig. 1E and the reporter gene results in
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Fig. 1G, the I-mut mutant is capable of repressing TNF-
message abundance, whereas the L-mut mutant cannot.
Calcium mobilization acts synergistically with lipin 1 deple-
tion to activate TNF- message and protein. To further ex-
plore the effects of NFAT derepression, we focused on the
expression of TNF-. The depletion of lipin 1 resulted in a
4-fold increase in TNF- expression (Fig. 7A). However, as
early as 2 h after the stimulation of Ca2 signaling by A23187,
there was a very robust (11-fold) increase in TNF- expres-
sion in lipin 1-deficient cells, whereas there was only a modest
(33%) increase in TNF- expression in gal-infected cells. In
contrast, overexpression of lipin 1 decreased basal expression
of TNF- and largely prevented the A23187-mediated increase
in TNF-.
CsA is a nonselective inhibitor of calcineurin activity. The
inhibitor of NFAT-calcineurin compounds (INCA) are small
organic molecules that are specific for inhibiting the interac-
tion between calcineurin and the NFAT transcription factors
(49). These compounds bind to the NFAT-calcineurin docking
site and prevent calcineurin-mediated dephosphorylation and
activation of NFAT. The addition of 3 M INCA6, like CsA,
also blocks the increase in TNF- message that occurs with
lipin 1 depletion confirming that this increase is mediated
through NFAT (Fig. 7B). As in Fig. 7A, A23187 addition to
cells lacking lipin 1 expression showed a dramatic activation of
TNF-, an effect that was blocked by the addition of CsA. In
order to verify that the increase of TNF- message levels was
functionally relevant, the secretion of TNF- by the cells into
the medium was examined. Figure 7C shows that the increased
TNF- message seen in lipin 1-depleted cells translated into
an increase in TNF- secretion; the combination of lipin 1
shRNA and A23187 leads to a striking further 10-fold increase
in TNF- secretion. In conclusion, depletion of lipin 1 in-
creases NFAT target gene expression. Activation of NFAT in
the context of lipin 1 depletion causes such a powerful induc-
tion of NFAT target genes to suggest that lipin 1 is a potent
repressor of activated NFAT.
Mice lacking lipin 1 exhibit increased expression of NFAT-
regulated genes. We examined what effect the loss of lipin 1
expression has on NFATc4 target gene expression in vivo using
FIG. 5. TSA reverses lipin 1-mediated repression of NFATc4. (A) BHK cells were transfected with expression vectors for FLAG-NFATc4 and
HA-lipin 1b and analyzed for transcriptional activation of NFAT-tk-luc in the presence or absence of 500 nM TSA pretreatment for 24 h (n 
 3).
(B) BHK cells were transfected as in panel A and subjected to coimmunoprecipitation as in Fig. 1A. (C) BHK cells were transfected with expression
vectors for Myc-tagged HDAC1-4 and HA-tagged lipin 1. Reciprocal immunoprecipitations using Myc or HA antibodies were performed, and
immune complexes were analyzed as in Fig. 1A. (D) ChIP assays with acetylated histone H3 antibodies were performed on 3T3-L1 adipocytes
infected and treated as described in the legend to Fig. 4F.
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visceral white adipose tissue (WAT) isolated from fld mice. In
agreement with previous observations (47) and consistent with
our findings in 3T3-L1 cells, we found increased expression of
PPAR and FABP4. In addition, the expression of resistin,
IL-6, and TNF- was markedly induced in fld WAT (Fig. 8).
These results are consistent with our observations in the
3T3-L1 model system and provide strong evidence that lipin 1
represses NFATc4 transcriptional activity not only in vitro but
also in vivo.
Decline in lipin 1 expression with increasing obesity in ob/ob
mice. To further evaluate whether lipin 1 could play a role in
obesity-induced inflammation, we examined the expression of
lipin 1 protein and total PAP activity in visceral and subcuta-
neous adipose tissue of ob/ob mice at different ages. At 8 weeks
FIG. 6. Depletion of lipin 1 in 3T3-L1 adipocytes induces the expression of NFAT-responsive genes. (A) Real-time PCR analysis of gene
expression in 3T3-L1 cells infected with adenovirus expressing LacZ or one of two different lipin 1 shRNAs (sh1 and sh2). In each experiment the
results shown are relative to LacZ expression (n 
 3 to 6). (B) Northern blot analysis of the indicated NFAT target genes in 3T3-L1 cells infected
with adenovirus expressing shRNA toward LacZ or lipin 1 (shRNA2). At 18 to 24 h before harvest, CsA (5 g/ml) was added, as indicated, to
inhibit NFAT activity. The results for confluent but undifferentiated 3T3-L1 preadipocytes are shown on the left (preadipocyte). (C) Real-time
PCR analysis of gene expression in 3T3-L1 cells infected with adenovirus expressing shRNA targeting LacZ or lipin 1 (sh2), and EGFP-tagged
VIVIT peptide. Where indicated, the cells were pretreated with PMA (50 nM) plus A23187 (1 M) for 18 h. The total amount of virus used for
infections was kept consistent using LacZ shRNA virus. (D) Real-time PCR analysis of gene expression in 3T3-L1 cells infected with adenovirus
expressing HA-tagged lipin 1b. The results were analyzed as described above for panel A, with the results normalized to control LacZ reference
on the left (Norm) (n 
 3). (E) Real-time PCR analysis of TNF- expression in 3T3-L1 cells infected with adenovirus expressing HA-tagged lipin
1b, the point mutants I-mut and L-mut, or shRNA2 (sh2). For panels D and E, the Student t test indicated a significant difference (P  0.05) from
LacZ alone ().
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of age there was a clear increase in lipin 1 protein and total
PAP activity in both visceral and subcutaneous adipose tissue
of ob/ob mice compared to lean controls (Fig. 9). However, by
12 weeks of age, lipin 1 protein levels in visceral adipose tissue
of ob/ob mice returned to lean control levels, which coincided
with a normalization of PAP activity (Fig. 9A and C). The
decline in lipin 1 level and PAP activity persisted throughout
19 weeks of age. Between 8 and 12 weeks of age there is a
dramatic increase in body weight in the ob/ob mice in parallel
with a significant increase in adipocyte hypertrophy (26, 53). It
is thus possible that the loss of lipin 1 expression is related to
metabolic complications, increased insulin resistance and glu-
cose intolerance, seen in the 12-week-old mice. Lipin 1 levels
decline during the acute phase response in adipocytes, most
likely due to the action of proinflammatory cytokines (33).
However, lipin 1 levels only declined in the visceral fat pads;
both lipin 1 and total PAP activity remained elevated in the
ob/ob subcutaneous fat pads even at 19 weeks of age (Fig. 9B
and C). This suggests that elevated levels of insulin, proinflam-
matory cytokines, and glucose are not necessarily responsible
for the decline in lipin 1 levels in ob/ob visceral fat since the
subcutaneous fat is also exposed to the same circulating fac-
tors. In addition, we observed an increase in lipin 2 expression
in the ob/ob visceral and subcutaneous fat pads which re-
mained elevated at all times examined (Fig. 9A and B). The
data presented here raise the possibility that a decline in lipin
1-mediated repression of NFAT may contribute to the in-
creased visceral fat pad secretion of proinflammatory cytokines
observed in ob/ob mice (17, 21). However, it should be ac-
knowledged that numerous events occur during the develop-
ment of obesity in ob/ob mice, not the least of which is the
absence of leptin signaling. Thus, decreased lipin 1 expression
and activity is unlikely to account for all of the changes in
inflammatory cytokine expression observed in these mice.
DISCUSSION
Previously, lipin 1 had been identified as a transcriptional
activator of PPAR and PPAR. Herein, we identify lipin 1 as
a repressor of NFATc4 transcriptional activity, a function that
does not seem to require lipin 1 lipid phosphatase activity. We
show that lipin 1 forms a complex with NFAT and DNA in vitro
FIG. 7. TNF- secretion is increased in response to depletion of
lipin 1-mediated repression of NFAT. (A) Time course of TNF-
mRNA expression in fully differentiated 3T3-L1 cells infected with
adenovirus expressing -galactosidase (gal), shRNA construct 1 tar-
geting lipin 1 (shRNA1), and HA-tagged lipin 1 (Lipin 1). At 4 days
postinfection, the cells were treated with A23187 (1 M) for the
indicated time. A significant increase () or decrease (#) from gal
infected cells (P  0.05) is indicated (n 
 2). (B) Real-time PCR
analysis of TNF- mRNA expression in differentiated 3T3-L1 cells
infected with adenovirus expressing shRNA toward LacZ (LacZ) or
lipin 1 (shRNA1 and shRNA2) for 4 days. At 18 to 24 h before harvest,
the cells were treated with CsA (5 g/ml), INCA-6 (3 M), A23187 (1
M), or A23187 (1 M) plus CsA (5 g/ml) (n 
 3 to 6). (C) Mea-
surement of TNF- protein secreted into the media (pg/ml) collected
from same cells used for experiments in panel B (n 
 4; , P  0.001
from LacZ; #, P  0.001 from LacZ plus A23187).
FIG. 8. Expression of NFAT target genes in fld mice. RNA was
isolated from gonadal fat pads from 42-day-old mice with the indicated
genotypes and analyzed by real-time PCR (n 
 4 to 5 animals for each
genotype).
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and is found in vivo at the promoters of NFAT target genes.
Precisely how lipin 1 functions to modulate transcriptional
activity is not entirely clear. Multiple lines of evidence from the
present study and others indicate that lipin 1 is physically
present at the promoters of regulated genes (12, 28). Our study
provides the first evidence for an interaction of the mammalian
lipin 1 protein with a non-nuclear receptor transcription factor.
With regard to PPAR, lipin 1 coactivates via cooperation with
the transcriptional coactivator PGC-1. However, this does
not occur with NFAT; instead, lipin 1 represses NFAT tran-
scriptional activity. The NFATs have been reported to tran-
scriptionally repress certain genes, notably CDK4 and VEGF
(2, 4). We found no effect on CDK4 mRNA expression in the
absence of lipin 1 (data not shown). However, VEGF mRNA
was induced with the loss of lipin 1 expression (data not
shown), suggesting that at least in 3T3-L1 cells lipin 1 may play
a role in the suppression of VEGF. The ability of TSA to
eliminate the repressive effects of lipin 1 on NFATc4 suggests
that the lipin 1-NFAT interaction alone is not sufficient for
repression but requires the lipin 1-mediated recruitment of an
HDAC. It was recently demonstrated that lipin 1 is SUMO-
ylated and that this controls lipin 1 nuclear translocation (31).
There is a growing awareness of the importance of SUMO-
ylation of transcriptional repressor complexes in the regulation
of transcription (13). Whether SUMOylation of lipin 1 is more
directly required for HDAC recruitment and transcriptional
repression is under investigation. Although our results suggest
that lipin 1 PAP activity is not required for either repression or
activation of transcription, it is possible that the overexpressed,
catalytically inactive lipin 1 proteins are either directly or in-
directly recruiting endogenous, enzymatically active lipin 1 (or
lipin 2 or 3), and it is the latter’s enzymatic function that
contributes to NFAT transcriptional suppression.
In differentiated 3T3-L1 adipocytes the loss of lipin 1 ex-
pression leads to a dramatic activation of NFAT transcrip-
tional targets that could be reversed with small molecule in-
hibitors of NFAT. Calcium mobilization in lipin 1-deficient
cells leads to a potent activation of NFAT target genes. These
findings suggest that lipin 1 may function as a gatekeeper for
NFAT activation in adipocytes. In concert with its role as a
lipid phosphatase, lipin may thus provide a novel link between
lipid metabolism, particularly synthesis of triacylglycerol, and
inflammation. In the obesity of adults, fat mass increases pri-
marily by adipocyte hypertrophy. Fat cell size strongly corre-
lates with adipose tissue inflammation and degree of macro-
phage infiltration, particularly in abdominal adipose tissue (5).
FIG. 9. Age-dependent decline in the expression of lipin 1 in ob/ob white adipose tissue (WAT). (A) Gonadal fat pads from ob/ob and ob/
mice were harvested for protein analysis at 8, 12, and 19 weeks of age. Shown are Western blots for lipin 1, lipin 2, and actin. (B) Subcutaneous
fat pads from ob/ob and ob/ mice were harvested for protein analysis at 8 and 19 weeks of age. Shown are Western blots for lipin 1, lipin 2, and
actin. (C) Total PAP activity in lysates from visceral and subcutaneous WAT of ob/ob and ob/ mice (n 
 3 to 6 for each genotype at each age).
A Student t test indicated significant differences between ob/ob and ob/ mice (; P 0.02 for visceral WAT at 8 weeks, P 0.03 for subcutaneous
WAT at 8 weeks, and P  0.005 for subcutaneous WAT at 19 weeks). The data are expressed as nmol of PA dephosphorylated/min/mg of protein.
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It is thought that adipocyte-secreted inflammatory factors,
such as TNF- and MCP1, function to recruit macrophages to
the fat tissue and/or convert resident macrophages to proin-
flammatory, activated macrophages (51). Because NFAT con-
tributes to proinflammatory cytokine expression in adipocytes,
the ability of lipin 1 to repress NFAT transcription may be
important for regulating macrophage recruitment to the fat
tissue. It should also be noted that the lipin 1 expression is
increased by the thiazolidinedione (TZD) class of anti-diabetic
drugs (11, 58). This is intriguing since the TZDs improve in-
sulin sensitivity and reduce inflammatory gene expression.
Consistent with lipin’s role in repressing NFAT target genes
that play a role in inflammation associated with obesity, we
found lipin expression declining with increasing obesity in
ob/ob mice. Given that triacylglycerol stores expand dramati-
cally in obese adipose tissue and lipin 1 plays a key role in
triacylglycerol biosynthesis, this might seem counterintuitive.
However, there is abundant evidence that this occurs. Many
years before the cloning of lipin 1, it was reported that PAP
activity declines with age in rodents (25). Because lipin 1 is
responsible for the majority of PAP activity in white adipose
tissue, it is likely that this earlier finding could be explained by
a decline in lipin 1 levels. In addition, two independent reports
have shown that adipose tissue lipin 1 mRNA levels are de-
creased in obese human subjects (7, 52). We found an age-
dependent decline in lipin 1 protein and total PAP activity in
visceral, but not subcutaneous, fat depots in ob/ob mice as they
progressively became more obese. Compared to subcutaneous
fat, visceral adipose tissue mass in obese subjects is more
closely linked to adipose inflammation. It is tempting to spec-
ulate that an obesity-driven decline in lipin 1 expression in
visceral adipose tissue contributes to depot-specific inflamma-
tion. Transgenic mice overexpressing lipin 1 in adipose tissue
are insulin sensitive, even when obese on a high fat diet, sug-
gesting decreased fat tissue inflammation (43). Moreover, ge-
netic variations in human LPIN1 are associated with insulin
resistance and the metabolic syndrome (reviewed in reference
45). In addition, several studies have found an inverse corre-
lation between lipin 1 expression in white adipose tissue and
inflammatory cytokine levels (30, 35). The data presented
herein showing the transcriptional repression of NFATc4 by
lipin may provide a molecular basis for this emerging link be-
tween lipin 1 and inflammation. We believe the positioning of
lipin 1 at an intersection between triacylglycerol synthesis and
expression of inflammatory genes is likely to have functional con-
sequences for the regulation of adipose tissue function.
TNF- is strongly induced by the knockdown of lipin 1. The
NFATs have long been known to be involved in the transcrip-
tion of TNF- in immune cells, and there are reports of
NFATc4 specifically inducing TNF- expression in lung cells
(10, 27, 34). Previous reports have indicated that macrophages
are responsible for the synthesis of the majority of TNF-
secreted from adipose tissue (51). However, the inability of
macrophages lacking TNF- to completely protect against high
fat diet-induced insulin resistance suggests that adipocyte-se-
creted TNF- may play an important role in the initial recruit-
ment of activated macrophages (8).
In conclusion, we have identified a non-nuclear receptor
transcription factor, NFATc4, that is regulated by interaction
with lipin 1. We have shown that lipin 1 represses the activity
of NFATc4 bound to DNA thus expanding the role of lipin 1
in regulating transcription factor activity. We also demon-
strated a decline in lipin 1 expression in a mouse model of
increased obesity and propose that this may couple obesity
with the activation of inflammatory pathways. Determining
ways of preventing lipin 1 from declining during obesity, or
blocking the loss of lipin 1-mediated repression of NFAT, may
lead to treatments that can prevent obesity-induced fat tissue
inflammation and subsequent insulin resistance.
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